Confirmed speakers:
Hugues Abriel, University of Bern, Switzerland
Eilika Weber-Ban, ETH Zurich, Switzerland
Nenad Ban, ETH Zurich, Switzerland
Marcus Bantscheff, Cellzome a Glaxo Smith Kline Company, Heidelberg, Germany
Michael Bergmann, Medical University of Vienna, Viena, Austria
Ozren Bogdanovic, Andalusian Centre for Developmental Biology, Sevilla, Spain
Ivana Carev, NAOS ILS Croatia, Mediterranean Institute for Life Sciences, Split, Croatia
Hans Clevers, Roche, Basel, Switzerland
Raymond Deshaies, Amgen Thousand Oaks, CA, USA
Michel Desjardins, University of Montreal, Canada
Boro Dropulić, Caring Cross, Gaithersburg, MD, USA
Ivana Gasic, University of Geneva, Switzerland
Thomas Jentsch, Max Delbrück Center for Molecular Medicine, Berlin
Anthony Kossiakoff, University of Chicago, IL, USA
Thomas Lemberger, Deputy Head Scientific Publications EMBO, Heidelberg, Germany
Kaspar Locher, ETH, Zurich,Switzerland
Juergen Reinhardt, Novartis Pharma, Basel, Switzerland
Uwe Sauer, ETH, Zurich, Switzerland
Berend Snijder, ETH Zurich, Switzerland
Igor Stagljar, University of Toronto, Canada and Mediterranean Institute for Life Sciences, Split, Croatia
Lovorka Stojic, Cancer Research, UK, Barts Center, London, United Kingdom
John Tallarico, Novartis Institutes for Biomedical Research (NIBR), Cambridge, Massachusetts, USA
Katarina Trajkovic, Mediterranean Institute for Life Sciences, Split, Croatia
Domagoj Vucic, Genentech, South San Francisco, USA
Henning Walczak, UCL Cancer Institute, London, UK and University of Cologne, Cologne, Germany
Erich Wanker, Max Delbrück Center for Molecular Medicine, Berlin, Germany
